Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 4 EP applications John Robert Hutchison has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 24, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12711872

ALISPORIVIR TO TREAT HEPATITIS C VIRUS INFECTION

IPC classification:
A61K 31/395, A61P 31/14
Applicant:
Novartis AG
Agent:
John Robert Hutchison, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12700262

IMMUNOSUPPRESSANT FORMULATIONS

IPC classification:
A61K 9/20, A61K 31/397
Applicant:
Novartis AG
Agent:
Ter Meer Steinmeister & Partner PartGmbB
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11727192

USE OF 1H-QUINAZOLINE-2,4-DIONES

IPC classification:
A61K 31/517, A61P 25/00
Applicant:
Novartis AG
Agent:
John Robert Hutchison, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP16169370

TREATMENT WITH VILDAGLIPTIN

IPC classification:
A61K 9/16, A61K 9/20
Applicant:
Novartis AG
Applicant:
Novartis Pharma GmbH
Agent:
John Robert Hutchison, Novartis AG
Status:
Request for examination was made

Please Sign in to use this feature